- Home
- TRUE vs NYXH Comparison
TRUE vs NYXH Comparison
Compare TRUE & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRUE | NYXH |
|---|---|---|
| Founded | 2005 | 2009 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.2M | 188.1M |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TRUE | NYXH |
|---|---|---|
| Price | $2.27 | $4.54 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $2.55 | ★ $12.67 |
| AVG Volume (30 Days) | ★ 741.3K | 26.3K |
| Earning Date | 02-17-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $181,222,000.00 | $6,616,215.00 |
| Revenue This Year | $9.14 | $75.27 |
| Revenue Next Year | $7.47 | $277.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 6.18 | ★ 10.96 |
| 52 Week Low | $1.05 | $4.35 |
| 52 Week High | $3.83 | $11.87 |
Technical Indicators
Market Signals| Indicator | TRUE | NYXH |
|---|---|---|
| Relative Strength Index (RSI) | 53.95 | 43.28 |
| Support Level | $2.29 | $4.47 |
| Resistance Level | $2.35 | $4.86 |
| Average True Range (ATR) | 0.06 | 0.19 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 54.72 | 18.21 |
Price Performance
Historical ComparisonAbout TRUE TrueCar Inc.
TrueCar Inc is a data-driven online platform operating on common technology infrastructure, powered by proprietary data and analytics. It also customizes and operates its platform for affinity group marketing partners, including financial institutions like PenFed and American Express; membership-based organizations like Consumer Reports, AARP, Sam's Club, and AAA; and employee buying programs for large enterprises such as IBM and Walmart. The Company has one operating segment, with three distinct service offerings: Dealer products and services, OEM incentives, and other.
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.